ClinicalTrials.Veeva

Menu

Efficacy of Totalfill® and ProRoot MTA® as Pulpotomy Agent in Primary Molars

U

University Ghent

Status and phase

Completed
Phase 4

Conditions

Extensively Decayed Primary Molars

Treatments

Drug: Totalfill
Drug: MTA

Study type

Interventional

Funder types

Other

Identifiers

NCT05149651
EC UZG 2016/0723 - 2016/0724

Details and patient eligibility

About

An experimental prospective double-blind, randomized clinical trial (RCT) with parallel design. To evaluate the outcome of using 2 pulpotomy agents: Totalfill® as study group and mineral trioxide aggregate (MTA®) as a control.

Full description

When a tooth decay is too deep and extended into the tooth pulp, then the tooth is not indicated to be treated with a filling. Therefore, removing the diseased pulp and then cover the rest with a suitable material is required. The Purpose of this study is to check the success of pulp treatment on deciduous molars with deep caries using 2 pulp treatment agents: (Totalfill® and MTA®). The use between the materials is randomly assigned. However, the use of the materials has no side effect or complications as it is a routine dental procedure.

The participants are healthy children aged between 3 and 9 years old, and the study is taking place in Ghent University Hospital, Ghent, Belgium, and it is planned to be conducted in duration of 4 years, which include 20 months for participants recruitment.

After placing the material, the tooth is restored with stainless steel crowns, and the participant was asked for follow up to check the tooth and to take dental x-ray every 6 months.

Enrollment

36 patients

Sex

All

Ages

3 to 9 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Patient inclusion criteria

    • ASA 1 patient, Patient is a completely healthy & fit. No allergy or medical conditions.
    • Patient is indicated for treatment under General Anesthesia: young age, uncooperative and extensive treatment plan.
    • Parent agreed to participate in the study, and signed the written consent.
    • Patient attended the out-patients pediatric dental clinic in UZ Gent.
  2. Tooth inclusion criteria 2.1. Clinical inclusion criteria:

    • Vital primary molars (first or second) with deep caries cavity with pulpal exposure.
    • Only mandibular primary molar were included
    • No spontaneous pain
    • No history of swelling
    • No sinus tract/ fistula
    • Absent of tenderness in percussion
    • No pathological mobility
    • Restorable tooth (stainless steel crown can be placed)
    • Hemostasis can be achieved with a dry cotton pellet after removal of Coronal pulp.

2.2. Radiographical inclusion criteria:

  • At least 2/3rd of root is present
  • Absence of internal or external root resorption
  • Absence of pathologic root resorption
  • Absence of periapical or furcation radiolucency

Exclusion criteria

If one or more of the criteria mentioned above is not fulfilled, the teeth were excluded from the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

36 participants in 2 patient groups

Totalfill
Experimental group
Description:
Totalfill® Bioceramic Root Repair Material -Fast Set Putty used as pulpotomy agent to treat extensive decayed tooth indicated for pulpotomy
Treatment:
Drug: Totalfill
MTA
Active Comparator group
Description:
ProRoot White MTA® used as pulpotomy agent to treat extensive decayed tooth indicated for pulpotomy
Treatment:
Drug: MTA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems